Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT-1D: Metformin for Peripheral Arterial Calcification in Type 1 Diabetes
NCT04583462Phase 3Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2021
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in arteriosclerosis obliterans, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2021; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on NCT04583462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04583462.